Cellular SignallingCell BiologyPeer-reviewed journal article
Calcitonin gene-related peptide and intermedin induce phosphorylation of p44/42 MAPK in primary human lymphatic endothelial cells in vitro
Shirin R. HasaniD, Dimitrios ManolisiD, Ewan Stephenson, Oktawia A. Ryskiewicz-Sokalska, Anthony MaraveyasiD, Leonid L. NikitenkoiD
Abstract
BackgroundCalcitonin gene-related peptide (CGRP) is a 37-amino acid peptide that belongs to the calcitonin family of peptides together with adrenomedullin (AM), adrenomedullin 2 (AM2), also known as intermedin (IMD), amylin (AMY) and calcitonin. Recent reports demonstrated the efficacy of drugs targeting CGRP signalling axis for the treatment of migraine, but also revealed significant side effects such as inflammation and microvascular complications, including aberrant neovascularisation in the skin. These findings highlight the importance of studying cellular targets of CGRP in human tissues. Recent studies using animal models implicate the role of CGRP in lymphangiogenesis and lymphatic vessel function. However, whether CGRP has direct effects on lymphatic endothelial cells (LEC) remains unknown. AimIn this study, we analysed phosphorylation of p44/42 mitogen-activated protein kinases (MAPK) in proliferating primary human dermal LEC (HDLEC) stimulated with CGRP and compared with responses to AM2/IMD and AM. Materials and MethodsPrimary breast HDLEC from two female donors (39 and 46 years old) were cultured in vitro. Cell viability and proliferation of sub-confluent HDLEC were confirmed by MTS assay and Ki67 immunostaining. Phosphorylation of p44/42 MAPK in HDLEC treated with CGRP, AM2/IMD or AM at different time points (1-30 min) and concentrations (10-12-10-6M) was assessed by immunoblotting. All experiments have been performed at least 4 times. Statistical analysis was done using Shapiro-Wilk and Kruskal Wallis tests followed by uncorrected Dunns test, with p<0.05 interpreted as significant. ResultsCGRP induced p44/42 MAPK phosphorylation in a time- and dose-dependent manner in proliferating primary HDLEC from both donors. p44/42 MAPK phosphorylation was induced by all three peptides (10-6M) at 5-15 min (p<0.05), but only CGRP-stimulated effect was sustained at 30 min. CGRP consistently induced p44/42 MAPK phosphorylation at 10-7-10-6M (p<0.05) in HDLEC from both donors, whilst responses to AM2/IMD and AM varied. ConclusionsOur study demonstrates that CGRP and AM2/IMD have direct effects on proliferating primary HDLEC. These new findings reveal CGRP and AM2/IMD as novel regulators of lymphatic endothelial cell biology and warrant further investigation of their roles in pathologies associated with lymphatic function in the skin and other organs.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: statistical model
- Citations
- 3
- FWCI
- 0.53
- Field percentile
- top 35%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The phosphodiesterase 2A regulates lymphatic endothelial development via cGMP-mediated control of Notch signaling
Claudia Carlantoni, Leon M.H. Liekfeld, … Maike Frye·bioRxiv·Jan 18, 2023
- The role of the meningeal lymphatic system in local inflammation and trigeminal nociception implicated in migraine pain
Nikita Mikhailov, Ksenia Koroleva, … Rashid A. Giniatullin·bioRxiv·Apr 25, 2020
- Amygdalar Calcitonin Gene-Related Peptide Driven Effects of Cold Sensitivity Induced by Peripheral Neuropathy in Mice
Alexis D Trail, Heather N. Allen, … Benedict James Kolber·Journal of PainPeer-reviewed·Jan 21, 2026
- CGRP-receptor family reveals endogenous GPCR agonist bias and its significance in primary human cardiovascular cells
A. Clark, N. Mullooly, … G. Ladds·bioRxiv·Dec 21, 2020
- Picomolar affinity antagonist and sustained signaling agonist peptide ligands for the adrenomedullin and calcitonin gene-related peptide receptors
J. M. Booe, M. L. Warner, A. A. Pioszak·bioRxiv·Feb 28, 2020
- The CGRP receptor antagonist BIBN4096 inhibits prolonged meningeal afferent activation evoked by brief local K+ stimulation but not cortical spreading depression-induced afferent sensitization